Articles tagged "Kidney transplantation"

2015 American Transplant Congress
A Noninvasive Diagnostic Test of Renal Allograft Rejection Using Urinary-Cell mRNA: A Comparison of Droplet Digital and Real-Time PCR
J.-W. Seo, H. Moon, A. Lee, Y.-W. Choi, Y. Kim, J.-Y. Moon, S.-H. Lee.
Division of Nephrology, Department on Internal Medicine, College of Medicine, Kyung Hee University, Seoul, Republic of Korea.
Background: The diagnosis of acute rejection in kidney transplantation is still standardized by an invasive renal biopsy. Noninvasive tests and biomarkers that can replace the…
2015 American Transplant Congress
The Feasibility of Utilising DCD Kidneys for Paediatric Recipients: Early Outcomes
Z. Ahmed,¹ R. Batra,¹ S. Marks,³ H. Jones,⁴ N. Mamode.¹
¹Renal and Pancreatic Transplantation, Guy's Hospital, London, United Kingdom; ²Abdominal Transplant Surgery, Mayo Clinic, Pheonix, AZ, United Kingdom; ³Paediatric Nephrology, Great Ormond Street Hospital, London, United Kingdom; ⁴Paediatric Nephrology, Evelina Children's Hospital, London, United Kingdom.
Introduction: Despite the widespread uptake of transplantation of kidneys from DCD donors, allocating such organs to paediatric recipients remains controversial; with no large case series…
2015 American Transplant Congress
Geographic Differences in HIV+ Kidney Transplant Waitlist Characteristics
J. Locke,¹ S. Gustafson,² C. Durand,³ J. Snyder,² B. Shelton,¹ R. Reed,¹ P. MacLennan,¹ S. Mehta,¹ A. Nellore,¹ D. Segev.^2,3
¹University of Alabama, Birmingham, Birmingham, AL; ²SRTR, MMRF, Minneapolis, MN; ³Johns Hopkins University, Baltimore, MD.
Kidney transplant (KT) is now a viable option for select HIV+ end-stage renal disease (ESRD) patients. As OPTN does not collect HIV status at waitlisting,…
2015 American Transplant Congress
Effect of Center Volume On Kidney Transplant Outcomes- Mate Kidney Analysis
T. Klair,¹ P. Friedmann,² L. Kayler.²
¹Abdominal Organ Transplant & Hepatobiliary Surgery, Columbia University Medical Center, New York, NY; ²Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY.
Background- Reports of the association of center volume and outcomes in kidney transplantation (KTX) may not provide adequate adjustment for donor risk factors. This study…
2015 American Transplant Congress
Renal Tubular Dysfunction Following Donor Nephrectomy and Its Impact On Residual Kidney Function
Z. Ahmed,¹ C. Rooney,³ C. Turner,² N. Dalton,² N. Kessaris,¹ N. Mamode.¹
¹Renal and Pancreatic Transplantation, Guy's Hospital, London, United Kingdom; ²Wellchild Laboratory, St Thomas' Hospital, London, United Kingdom; ³Faculty of Medicine, King's College London, London, United Kingdom.
Background: Recent publications have described an increasing incidence of end stage renal disease amongst kidney donors. This highlights the paucity of knowledge which exists in…
2015 American Transplant Congress
Epidemiology of Pneumonia in a Cohort of 5,000+ Abdominal Solid Organ Transplant Recipients
A. Masica, S. Delcroix-Lopes, M. Kouznetsova, C. Spak.
Baylor Scott & White Health, Dallas, TX.
Study purposeWe evaluated the epidemiology of pneumonia (PNE) in a longitudinal cohort of patients with abdominal (kidney, liver, and/or pancreas) solid organ transplants (SOT).MethodsRetrospective study…
2015 American Transplant Congress
Favorable Results of ABO Incompatible Renal Transplantation Without B Cell Targeted Therapy: Advantages and Disadvantages of Rituximab Pretreatment
M. Okada,¹ K. Futamura,¹ K. Itou,¹ T. Yamamoto,¹ T. Hiramitsu,¹ M. Tsujita,¹ N. Goto,¹ S. Narumi,¹ Y. Watarai,¹ A. Katayama,² K. Uchida,³ T. Kobayashi.⁴
¹Nagoya Daini Red Cross Hospital, Nagoya, Japan; ²Masuko Memorial Hospital, Nagoya, Japan; ³Aichi Medical University, Nagakute, Japan; ⁴Nagoya University School of Medicine, Nagoya, Japan.
INTRODUCTIONThe outcome of ABO-incompatible transplantation (ABO-I) has been reported to be comparable to that of ABO-identical/compatible transplantation (ABO-Id/C), which is considered to be due to…
2015 American Transplant Congress
A Common Gene Signature Across Multiple Studies Identifies Biomarkers and Functional Regulation in Tolerance to Renal Allograft
D. Baron,^1,2,3 G. Ramstein,⁴ M. Chesneau,^1,2,3 Y. Echasseriau,^1,2,3 A. Pallier,^1,2,3 C. Paul,^1,2,3 N. Degauque,^1,2,3 M. Hernandez-Fuentes,⁵ A. Sanchez-Fueyo,⁶ K. Newell,⁷ M. Giral,^1,2,3 J.-P. Soulillou,^1,2,3 R. Houlgatte,^8,9 S. Brouard.^1,2,3
¹UMR 1064 - CRTI, INSERM, Nantes, Loire Atlantique (44), France; ²ITUN, CHU de Nantes, Nantes, Loire Atlantique (44), France; ³Faculté de Médecine, Université de Nantes, Nantes, Loire Atlantique (44), France; ⁴UMR 6241 - LINA, Université de Nantes, Nantes, Loire Atlantique (44), France; ⁵MRC Centre for Transplantation, King's College London, London, United Kingdom; ⁶Institute of Liver Studies, King's College Hospital, London, United Kingdom; ⁷Department of Surgery, Emory University, Atlanta, GA; ⁸U954 - LNGERE, INSERM, Nancy, France; ⁹DRCI, CHU de Nancy, Nancy, France.
Patients tolerant to a kidney graft display a specific blood transcriptional pattern but reported results from five distinct studies hardly overlapped, raising the question of…
2015 American Transplant Congress
Survival Benefit of Kidney Transplantation With Expanded Criteria Kidney from Donors After Circulatory Death
X. Luo, A. Massie, E. Chow, D. Segev.
Johns Hopkins, Baltimore.
The purpose of this study was to compare the mortality risk and survival benefit of transplant with expanded criteria kidneys from donors after circulatory death…
2015 American Transplant Congress
Comparison of Efficacy of Prophylactic Antivirus Therapies on Outcomes of Kidney Transplantation in Hepatitis B Virus Carriers
G. Chen, C. Wang, J. Qiu, J. Li, L. Chen.
Organ Transplant Center, The first affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Purpose To compare the efficacy between entecavir and lamivudine as prophylactic antivirus therapy on long-term outcomes of HBV carriers after kidney transplantation.Methods We retrospectively reviewed…